老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Milestone Pharmaceuticals Inc.

1.87
-0.0100-0.53%
成交量：36.59萬
成交額：69.36萬
市值：1.59億
市盈率：-2.23
高：1.95
開：1.93
低：1.87
收：1.88
52周最高：2.75
52周最低：0.6254
股本：8,499.43萬
流通股本：7,881.45萬
量比：0.63
換手率：0.46%
股息：- -
股息率：- -
每股收益(TTM):-0.8376
每股收益(LYR):-0.6674
淨資產收益率：-780.29%
總資產收益率：-50.33%
市淨率：-8.96
市盈率(LYR):-2.80

資料載入中...

總覽公司新聞公告
2021/03/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/29

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/21

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/16

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/26

重要事件披露

8-K - Current report
2020/10/23

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/09/22

重要事件披露

8-K - Current report
2020/08/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/03

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/29

重要事件披露

8-K - Current report
2020/07/23

重要事件披露

8-K - Current report
更多